Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis
Status:
Terminated
Trial end date:
2020-12-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and
efficacy of JBT-101 in adult subjects with diffuse cutaneous systemic sclerosis.